title: [MEC treatment (methotrexate, etoposide, cisplatin) for urothelial cancer].
authors.affiliation: Department of Urology, Kanagawa Prefectural Cancer Center, Yokohama, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Miura
authors.forename: T
authors.initials: T
authors.lastname: Murai
authors.forename: H
authors.initials: H
authors.lastname: Shimura
authors.forename: I
authors.initials: I
authors.lastname: Kondo
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy*; D002945:Cisplatin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
chemical_list: D005047:Etoposide; D002945:Cisplatin; D008727:Methotrexate